Lilly (LLY) and Incyte's (INCY) Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Go back to Lilly (LLY) and Incyte's (INCY) Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 StudyIncyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 56.97 -0.15 (0.26%) | |||||
---|---|---|---|---|---|---|
Previous Close | $57.12 | 52 Week High | $118.49 | |||
Open | $57.25 | 52 Week Low | $55.00 | |||
Day High | $57.09 | P/E | N/A | |||
Day Low | $56.77 | EPS | $-0.56 | |||
Volume | 1,883,242 |
Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 777.96 -0.22 (0.03%) | |||||
---|---|---|---|---|---|---|
Previous Close | $778.18 | 52 Week High | $88.16 | |||
Open | $780.32 | 52 Week Low | $67.88 | |||
Day High | $793.67 | P/E | 180.08 | |||
Day Low | $776.44 | EPS | $4.32 | |||
Volume | 3,209,069 |